atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity (original) (raw)

References

  1. Savitsky, K. et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268, 1749–1753 (1995).
    Article CAS Google Scholar
  2. Srivastava, S., Zou, Z.Q., Pirollo, K., Blattner, W. & Chang, E.H. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348, 747–749 (1990).
    Article CAS Google Scholar
  3. Malkin, D. et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250, 1233–1238 (1990).
    Article CAS Google Scholar
  4. Meyn, M.S. Ataxia-telangiectasia and cellular responses to DNA damage. Cancer Res. 55, 5991–6001 (1995).
    CAS PubMed Google Scholar
  5. Hawley, R.S. & Friend, S.H. Strange bedfellows in even stranger places: the role of ATM in meiotic cells, lymphocytes, tumors, and its functional links to p53. Genes Dev. 10, 2383–2388 (1996).
    Article CAS Google Scholar
  6. Enoch, T. & Norbury, C. Cellular responses to DNA damage: cell-cycle checkpoints, apoptosis and the roles of p53 and ATM. Trends Biochem. Sci. 20, 426–430 (1995).
    Article CAS Google Scholar
  7. Kastan, M.B. et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71, 587–597 (1992).
    Article CAS Google Scholar
  8. Meyn, M.S., Strasfeld, L. & Allen, C. Testing the role of p53 in the expression of genetic instability and apoptosis in ataxia-telangiectasia. Int. J. Radiat. Biol. 66, S141–S149 (1994).
    Article CAS Google Scholar
  9. Westphal, C.H. et al. Genetic interactions between atm and p53 influence cellular proliferation and irradiation-induced cell cycle checkpoints. Cancer Res. 57, 1664–1667 (1997).
    CAS PubMed Google Scholar
  10. Xu, Y. & Baltimore, D. Dual roles of ATM in the cellular response to radiation and in cell growth control. Genes Dev. 10, 2401–2410 (1996).
    Article CAS Google Scholar
  11. Elson, A. et al. Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc. Natl. Acad. Sci. USA 93, 13084–13089 (1996).
    Article CAS Google Scholar
  12. Barlow, C. et al. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86, 159–171 (1996).
    Article CAS Google Scholar
  13. Donehower, L.A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215–221 (1992).
    Article CAS Google Scholar
  14. Jacks, T. et al. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4, 1–7 (1994).
    Article CAS Google Scholar
  15. Clarke, A.R. et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362, 849–852 (1993).
    Article CAS Google Scholar
  16. Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A. & Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362, 847–849 (1993).
    Article CAS Google Scholar
  17. Lu, X. & Lane, D.P. Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes. Cell 75, 765–778 (1993).
    Article CAS Google Scholar
  18. Canman, C.E., Wolff, A.C., Chen, C.Y., Fornace, A.J., Jr. & Kastan, M.B. The p53-dependent G1 cell cycle checkpoint pathway and ataxia- telangiectasia. Cancer Res. 54, 5054–5058 (1994).
    CAS PubMed Google Scholar
  19. Lavin, M.F. & Shiloh, Y. The genetic defect in ataxia-telangiectasia. Annu. Rev. Immunol. 15, 177–202 (1996).
    Article Google Scholar
  20. Donehower, L.A. et al. Effects of genetic background on tumorigenesis in p53-deficient mice. Mol. Carcinog. 14, 16–22 (1995).
    Article CAS Google Scholar
  21. Gotoff, S.P., Amirmokri, E. & Liebner, E.J. Ataxia telangiectasia: neoplasia, untoward response to X-irradiation, and tuberous sclerosis. Am. J. Dis. Child. 114, 617–625 (1967).
    Article CAS Google Scholar
  22. Cunliffe, P.M., Mann, J.R., Cameron, A.H. & Roberts, K.D. Radiosensitivity in ataxia-telangiectasia. Br. J. Radiol. 48, 374–376 (1975).
    Article Google Scholar
  23. Morgan, J.L., Holcomb, T.M. & Morissey, R.W. Radiation reaction in ataxia telangiectasia. Am. J. Dis. Child. 116, 557–559 (1968).
    CAS PubMed Google Scholar
  24. Morgan, S.E., Lovly, C., Pandita, T.K., Shiloh, Y. & Kastan, M.B. Fragments of atm which have dominant-negative or complementing activity. Mol. Cell. Biol. 17, 2020–2029 (1997).
    Article CAS Google Scholar
  25. Fisher, D.E. Apoptosis in cancer therapy: crossing the threshold. Cell 78, 539–542 (1994).
    Article CAS Google Scholar
  26. Jacks, T. & Weinberg, R.A. Cell-cycle control and its watchman. Nature 381, 643–644 (1996).
    Article CAS Google Scholar
  27. Lowe, S.W., Ruley, H.E., Jacks, T. & Housman, D.E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74, 957–967 (1993).
    Article CAS Google Scholar
  28. Lowe, S.W. et al. p53 status and the efficacy of cancer therapy in vivo. Science 266, 807–810 (1994).
    Article CAS Google Scholar

Download references